Teva Pharmaceutical Industries (TEVA) Shares Outstanding: 2009-2025
Historic Shares Outstanding for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Sep 2025 value amounting to $1.3 billion.
- Teva Pharmaceutical Industries' Shares Outstanding rose 1.05% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1.05%. This contributed to the annual value of $1.2 billion for FY2024, which is 1.06% up from last year.
- Teva Pharmaceutical Industries' Shares Outstanding amounted to $1.3 billion in Q3 2025, which was down 0.00% from $1.3 billion recorded in Q2 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Shares Outstanding peaked at $1.3 billion during Q1 2025, and registered a low of $1.2 billion during Q1 2021.
- For the 3-year period, Teva Pharmaceutical Industries' Shares Outstanding averaged around $1.2 billion, with its median value being $1.2 billion (2024).
- Data for Teva Pharmaceutical Industries' Shares Outstanding shows a peak YoY grew of 1.21% (in 2025) over the last 5 years.
- Teva Pharmaceutical Industries' Shares Outstanding (Quarterly) stood at $1.2 billion in 2021, then climbed by 0.66% to $1.2 billion in 2022, then increased by 0.82% to $1.2 billion in 2023, then climbed by 1.06% to $1.2 billion in 2024, then increased by 1.05% to $1.3 billion in 2025.
- Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.